Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natriuretic Peptide Receptor Type B (NPRB or NPR2) is an essential single-pass transmembrane receptor with intrinsic guanylate cyclase activity. It primarily binds C-type natriuretic peptide to regulate vascular tone, renal function, and skeletal development via cGMP-mediated signaling pathways. Mutations in its gene are linked to specific skeletal dysplasias.
Activation of guanylyl cyclase leading to increased intracellular cGMP levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atrial Natriuretic Peptide Receptor Type B (NPRB).